STOCK TITAN

Johnson & Johnson (NYSE: JNJ) EVP exercises options, sells 23,054 shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vanessa Broadhurst, EVP, Global Corp Affairs at Johnson & Johnson, exercised employee stock options for 11,129 and 11,925 shares of Common Stock on July 20, 2026 at exercise prices of $129.5100 and $131.9400 per share, then sold 23,054 shares in transactions described as open market or private at a weighted average price of $251.2660 per share. These options were awarded under the issuer's Long-Term Incentive Plan and become exercisable on the third anniversary of the grant date.

Positive

  • None.

Negative

  • None.
Insider Broadhurst Vanessa
Role EVP, Global Corp Affairs
Sold 23,054 shs ($5.79M)
Approx. gross sale proceeds $5.79M
Approx. exercise cost $3.01M
Approx. pre-tax spread $2.78M
Type Security Shares Price Value
Exercise Employee Stock Options (Right to Buy) F2 11,129 $0.00 $0.00
Exercise Employee Stock Options (Right to Buy) F2 11,925 $0.00 $0.00
Exercise Common Stock 11,129 $129.51 $1.44M
Exercise Common Stock 11,925 $131.94 $1.57M
Sale Common Stock F1 23,054 $251.266 $5.79M
Holdings After Transaction: Employee Stock Options (Right to Buy) — 0 shares (Direct); Common Stock — 23,003 shares (Direct)
Footnotes (2)
  1. F1. This transaction was executed in multiple trades at prices ranging from $251.09 to $251.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. F2. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Common shares sold 23054 shares Common Stock sale on 2026-07-20 at weighted average $251.2660 per share
Weighted average sale price $251.2660 per share Price for 23,054-share sale, with individual trades between $251.09 and $251.555
Options exercised (2021 grant) 11129 shares Employee Stock Options (Right to Buy) exercised at $129.5100 per share, expiring 2028-02-11
Exercise price, 2021 grant $129.5100 per share Conversion of Employee Stock Options into 11,129 Common Stock shares on 2026-07-20
Options exercised (2022 grant) 11925 shares Employee Stock Options (Right to Buy) exercised at $131.9400 per share, expiring 2029-02-11
Exercise price, 2022 grant $131.9400 per share Conversion of Employee Stock Options into 11,925 Common Stock shares on 2026-07-20
Employee Stock Options (Right to Buy) financial
"security_title shows Employee Stock Options (Right to Buy) on derivative rows"
Long-Term Incentive Plan financial
"Footnote F2 states awards were under the Issuer's Long-Term Incentive Plan"
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
weighted average sale price financial
"Footnote F1 explains the price is a weighted average sale price over multiple trades"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transactions did Vanessa Broadhurst report for Johnson & Johnson (JNJ)?

Vanessa Broadhurst reported exercising employee stock options for 11,129 and 11,925 Johnson & Johnson shares and then selling 23,054 Common Stock shares. The sale used a weighted average price of $251.2660 per share across multiple trades on July 20, 2026.

How many Johnson & Johnson (JNJ) shares did Vanessa Broadhurst sell and at what price?

She sold 23,054 shares of Johnson & Johnson Common Stock at a weighted average price of $251.2660 per share. Footnote disclosure states the trades were executed between $251.09 and $251.555, with the reported price reflecting the weighted average sale price.

What stock options did Vanessa Broadhurst exercise in this JNJ Form 4 filing?

She exercised 11,129 Employee Stock Options at an exercise price of $129.5100 per share and 11,925 Employee Stock Options at $131.9400 per share. Both option awards were granted under the issuer's Long-Term Incentive Plan and have stated expiration dates in 2028 and 2029.

Under what plan were the options in Vanessa Broadhurst’s JNJ filing granted?

Footnote F2 states the stock option awards were granted under Johnson & Johnson's Long-Term Incentive Plan. The plan provides that each Stock Option Award vests and is exercisable on the third anniversary of the grant date before the stated expiration.

Were Vanessa Broadhurst’s JNJ share sales single-price or multiple trades?

The sale was executed in multiple trades, not a single-price block. Footnote F1 explains the transactions occurred at prices ranging from $251.09 to $251.555, with the Form 4 reporting a weighted average sale price of $251.2660 per share.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Broadhurst Vanessa

(Last)(First)(Middle)
ONE JOHNSON & JOHNSON PLAZA

(Street)
NEW BRUNSWICK NEW JERSEY 08933

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Global Corp Affairs
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/20/2026M11,129A$129.5134,132D
Common Stock07/20/2026M11,925A$131.9446,057D
Common Stock07/20/2026S23,054D$251.266(1)23,003D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Options (Right to Buy)$129.5107/20/2026M11,12902/12/2021(2)02/11/2028Common Stock11,129$00D
Employee Stock Options (Right to Buy)$131.9407/20/2026M11,92502/11/2022(2)02/11/2029Common Stock11,925$00D
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $251.09 to $251.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Remarks:
/s/ Joleen Morgan, as attorney-in-fact for Vanessa Broadhurst07/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)